Jasmin Wertz summarises the recently published IMPACT trial, which found that CBT, short-term psychoanalytical psychotherapy and brief psychosocial interventions (psychoeducation) were all equally effective in treating depression in children and young people.
[read the full story...]
Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.
[read the full story...]
Joe Barnby publishes his debut elf blog on a recent randomised controlled trial of virtual reality compared with in vivo exposure in the treatment of social anxiety disorder.
[read the full story...]
Samei Huda highlights a recent RCT of antipsychotics (risperidone and haloperidol) versus placebo for symptoms of delirium in palliative care, which suggests we need non-drug alternatives for this group of patients.
[read the full story...]
A repost of Simon Leigh’s excellent recent article in Evidence-Based Mental Health on the clear need for consensus and guidance for app developers, as to which patient-reported outcome measures should be used when developing mental health apps.
[read the full story...]
Matt Field considers a recent meta-analysis that explores the effectiveness of Cognitive Bias Modification interventions for substance addictions.
[read the full story...]
Elizabeth Collier writes her debut blog on the REMCARE randomised controlled trial of reminiscence groups for people with dementia and their family carers.
[read the full story...]
John Baker looks at the 2-year follow-up results of a cluster RCT on the effectiveness of financial incentives to improve adherence to maintenance treatment with depot antipsychotics.
[read the full story...]
John Baker evaluates the recent TEMPO cluster RCT, which explores training to enhance psychiatrist communication with patients who live with psychosis.
[read the full story...]
Ben Hannigan reports on a recent RCT of the efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression.
[read the full story...]
